Quantitative In Situ Measurement of Estrogen Receptor mRNA Predicts Response to Tamoxifen
Jennifer Bordeaux(Lineage Cell Therapeutics (United States)), David L. Rimm(Yale University), Bruce G. Haffty(Rutgers, The State University of New Jersey), Xiaojun Ma(Advanced Cell Diagnostics (United States)), Huan Cheng(Yale University), Allison W. Welsh(Yale University), Yuling Luo(The First Affiliated Hospital, Sun Yat-sen University), Donald R. Lannin(Yale University), Xingyong Wu(Quantum Devices (United States)), Nan Su(Army Medical University)
Cited by 62
Related Papers
RNAscope
|Journal of Molecular Diagnostics|2011|2.7k
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots
|Nature Biotechnology|2002|2.5k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
|Nature|2005|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k